Skip to main content
Log in

Clinicopathological and molecular characterization of three cases classified by DNA-methylation profiling as “Glioneuronal Tumors, NOS, Subtype A”

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Guerreiro Stucklin AS, Ryall S, Fukuoka K, Zapotocky M, Lassaletta A, Li C et al (2019) Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas. Nat Commun 10:4343. https://doi.org/10.1038/s41467-019-12187-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Gupte A, Marupudi NI, Mody S, Kupsky W, Gorsi HS (2021) BCR-NTRK2 fusion in a pediatric patient with spinal gangliocytoma. Pediatr Blood Cancer 68:e29029. https://doi.org/10.1002/pbc.29029

    Article  PubMed  Google Scholar 

  3. Huse JT, Edgar M, Halliday J, Mikolaenko I, Lavi E, Rosenblum MK (2013) Multinodular and vacuolating neuronal tumors of the cerebrum: 10 cases of a distinctive seizure-associated lesion. Brain Pathol Zurich Switz 23:515–524. https://doi.org/10.1111/bpa.12035

    Article  Google Scholar 

  4. Jones DTW, Hutter B, Jäger N, Korshunov A, Kool M, Warnatz H-J et al (2013) Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet 45:927–932. https://doi.org/10.1038/ng.2682

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D et al (2021) The 2021 WHO Classification of tumors of the central nervous system: a summary. Neuro-Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Lucas C-HG, Abdullaev Z, Bruggers CS, Mirchia K, Whipple NS, Alashari MM et al (2022) Activating NTRK2 and ALK receptor tyrosine kinase fusions extend the molecular spectrum of pleomorphic xanthoastrocytomas of early childhood: a diagnostic overlap with infant-type hemispheric glioma. Acta Neuropathol (Berl) 143:283–286. https://doi.org/10.1007/s00401-021-02396-y

    Article  CAS  Google Scholar 

  7. Qaddoumi I, Orisme W, Wen J, Santiago T, Gupta K, Dalton JD et al (2016) Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Acta Neuropathol (Berl) 131:833–845. https://doi.org/10.1007/s00401-016-1539-z

    Article  CAS  Google Scholar 

  8. Sievers P, Stichel D, Schrimpf D, Sahm F, Koelsche C, Reuss DE et al (2018) FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma. Acta Neuropathol (Berl) 136:293–302. https://doi.org/10.1007/s00401-018-1882-3

    Article  CAS  Google Scholar 

  9. Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D et al (2016) New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164:1060–1072. https://doi.org/10.1016/j.cell.2016.01.015

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Torre M, Vasudevaraja V, Serrano J, DeLorenzo M, Malinowski S, Blandin A-F et al (2020) Molecular and clinicopathologic features of gliomas harboring NTRK fusions. Acta Neuropathol Commun 8:107. https://doi.org/10.1186/s40478-020-00980-z

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We are thankful for the laboratory technicians at GHU Paris Neuro Sainte-Anne Hospital for their assistance, the Integragen platform for their technical assistance with DNA-methylation analyses and the support of RENOCLIP-LOC, the clinico-pathologic network instrumental in the central histopathologic review supported by the Institut National du Cancer (INCa). We would like to thank Philipp Sievers from Heidelberg for performing the t-SNE analysis.

Funding

The authors declare that they have not received any funding.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

ATE, VDR, DFB, BA, DS, BT, NG, VJ, AL, NA and NB compiled the MRI and clinical records; ATE, DFB, GC, MCM, AM, FC and PV conducted the neuropathological examinations; ATE, DFB, EUC, YN, AR, LB, FLL, IH, MT, and PV conducted the molecular studies; ATE, VDR, DFB, NB and PV drafted the manuscript; all the authors reviewed the manuscript.

Corresponding author

Correspondence to Arnault Tauziède-Espariat.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest directly related to the topic of this article.

Ethics approval

This study was approved by the GHU Paris Psychiatry and Neurosciences, Sainte-Anne Hospital’s local ethic committee.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tauziède-Espariat, A., Volodia-Dangouloff-Ros, Figarella-Branger, D. et al. Clinicopathological and molecular characterization of three cases classified by DNA-methylation profiling as “Glioneuronal Tumors, NOS, Subtype A”. Acta Neuropathol 144, 1179–1183 (2022). https://doi.org/10.1007/s00401-022-02490-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-022-02490-9

Navigation